Literature DB >> 2661589

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

L C Groop1, R C Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, R A DeFronzo.   

Abstract

The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661589      PMCID: PMC303971          DOI: 10.1172/JCI114142

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Relation of fatty acid oxidation tgluconeogenesis: effect of pentenoic acid.

Authors:  N Ruderman; E Shafrir; R Bressler
Journal:  Life Sci       Date:  1968-10-15       Impact factor: 5.037

2.  Measurement and validation of nonsteady turnover rates with applications to the inulin and glucose systems.

Authors:  J Radziuk; K H Norwich; M Vranic
Journal:  Fed Proc       Date:  1974-07

3.  Human forearm muscle metabolism during exercise. VII. FFA uptake and oxidation at different work intensities.

Authors:  L Hagenfeldt; J Wahren
Journal:  Scand J Clin Lab Invest       Date:  1972-12       Impact factor: 1.713

Review 4.  Regulation of hepatic glucose metabolism in humans.

Authors:  R A DeFronzo; E Ferrannini
Journal:  Diabetes Metab Rev       Date:  1987-04

5.  Non-steady state: error analysis of Steele's model and developments for glucose kinetics.

Authors:  C Cobelli; A Mari; E Ferrannini
Journal:  Am J Physiol       Date:  1987-05

6.  Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus.

Authors:  Y D Chen; A Golay; A L Swislocki; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

7.  Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.

Authors:  A Golay; A L Swislocki; Y D Chen; G M Reaven
Journal:  Metabolism       Date:  1987-07       Impact factor: 8.694

8.  Uptake of individual free fatty acids by skeletal muscle and liver in man.

Authors:  L Hagenfeldt; J Wahren; B Pernow; L Räf
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

9.  Validation of a new method for determination of free fatty acid turnover.

Authors:  J M Miles; M G Ellman; K L McClean; M D Jensen
Journal:  Am J Physiol       Date:  1987-03

10.  Effect of glucose ingestion on the metabolism of free fatty acids in human subjects.

Authors:  C Waterhouse; N Baker; H Rostami
Journal:  J Lipid Res       Date:  1969-09       Impact factor: 5.922

View more
  218 in total

1.  Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study.

Authors:  Leonard C Glass; Kenneth Cusi; Rachele Berria; Roberta Petz; Eugenio Cersosimo; Ralph A Defronzo; Amalia Gastaldelli
Journal:  Clin Endocrinol (Oxf)       Date:  2010-04-23       Impact factor: 3.478

Review 2.  Ectopic fat accumulation: an important cause of insulin resistance in humans.

Authors:  Hannele Yki-Järvinen
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 3.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 4.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 5.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

6.  β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprolol.

Authors:  Orly Vardeny; Gabriel Nicholas; Alina Andrei; Kevin A Buhr; Matt P Hermanson; John J Moran; Michelle A Detry; James H Stein
Journal:  Am J Hypertens       Date:  2012-05-31       Impact factor: 2.689

7.  Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.

Authors:  A Avogaro; G Toffolo; M Miola; A Valerio; A Tiengo; C Cobelli; S Del Prato
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 8.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

9.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

Review 10.  Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor.

Authors:  Ralph A DeFronzo
Journal:  Diabetes Obes Metab       Date:  2017-06-07       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.